Tuesday, October 28, 2014

Indian drugmaker Ranbaxy still has exclusive rights for Nexium generic: CEO

Ranbaxy Laboratories's Chief Executive Sawhney poses for a picture at his office in Gurgaon on the outskirts of New Delhi MUMBAI (Reuters) - Indian drugmaker Ranbaxy Laboratories still has exclusive rights to the launch of AstraZeneca's heartburn drug Nexium in the United States, it said on Tuesday, despite regulatory concern over the manufacturing process. Ranbaxy was the first to seek approval from the U.S. Food and Drug Administration (FDA) to sell a cheaper copy of Nexium, gaining exclusive rights to sell it for six months after patent expiry. ...








via Health News Headlines - Yahoo News http://ift.tt/1DWVfKv
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)